A review of the volatiles from the healthy human body B de Lacy Costello, A Amann, H Al-Kateb, C Flynn, W Filipiak, T Khalid, ... Journal of breath research 8 (1), 014001, 2014 | 1106 | 2014 |
Noninvasive detection of lung cancer by analysis of exhaled breath A Bajtarevic, C Ager, M Pienz, M Klieber, K Schwarz, M Ligor, T Ligor, ... BMC cancer 9, 1-16, 2009 | 734 | 2009 |
TD-GC-MS Analysis of Volatile Metabolites of Human Lung Cancer and Normal Cells In vitro W Filipiak, A Sponring, A Filipiak, C Ager, J Schubert, W Miekisch, ... Cancer epidemiology, biomarkers & prevention 19 (1), 182-195, 2010 | 273 | 2010 |
Molecular analysis of volatile metabolites released specifically by staphylococcus aureus and pseudomonas aeruginosa W Filipiak, A Sponring, MM Baur, A Filipiak, C Ager, H Wiesenhofer, ... BMC microbiology 12, 1-16, 2012 | 268 | 2012 |
Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants W Filipiak, V Ruzsanyi, P Mochalski, A Filipiak, A Bajtarevic, C Ager, ... Journal of breath research 6 (3), 036008, 2012 | 236 | 2012 |
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro W Filipiak, A Sponring, T Mikoviny, C Ager, J Schubert, W Miekisch, ... Cancer cell international 8, 1-11, 2008 | 229 | 2008 |
Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study J King, P Mochalski, A Kupferthaler, K Unterkofler, H Koc, W Filipiak, ... Physiological measurement 31 (9), 1169, 2010 | 216 | 2010 |
Breath acetone—aspects of normal physiology related to age and gender as determined in a PTR-MS study K Schwarz, A Pizzini, B Arendacká, K Zerlauth, W Filipiak, A Schmid, ... Journal of Breath Research 3 (2), 027003, 2009 | 215 | 2009 |
Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro A Sponring, W Filipiak, T Mikoviny, C Ager, J Schubert, W Miekisch, ... Anticancer research 29 (1), 419-426, 2009 | 190 | 2009 |
Breath isoprene–aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study I Kushch, B Arendacká, S Štolc, P Mochalski, W Filipiak, K Schwarz, ... Clinical chemistry and laboratory medicine 46 (7), 1011-1018, 2008 | 183 | 2008 |
Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers W Filipiak, A Filipiak, A Sponring, T Schmid, B Zelger, C Ager, ... Journal of breath research 8 (2), 027111, 2014 | 166 | 2014 |
Determining concentration patterns of volatile compounds in exhaled breath by PTR-MS K Schwarz, W Filipiak, A Amann Journal of Breath Research 3 (2), 027002, 2009 | 163 | 2009 |
A compendium of volatile organic compounds (VOCs) released by human cell lines W Filipiak, P Mochalski, A Filipiak, C Ager, R Cumeras, C E Davis, ... Current medicinal chemistry 23 (20), 2112-2131, 2016 | 136 | 2016 |
Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS W Filipiak, A Sponring, MM Baur, C Ager, A Filipiak, H Wiesenhofer, ... Microbiology 158 (12), 3044-3053, 2012 | 117 | 2012 |
Breath analysis for in vivo detection of pathogens related to ventilator-associated pneumonia in intensive care patients: a prospective pilot study W Filipiak, R Beer, A Sponring, A Filipiak, C Ager, A Schiefecker, ... Journal of breath research 9 (1), 016004, 2015 | 115 | 2015 |
Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells A Sponring, W Filipiak, C Ager, J Schubert, W Miekisch, A Amann, ... Cancer Biomarkers 7 (3), 153-161, 2010 | 104 | 2010 |
SPME in clinical, pharmaceutical, and biotechnological research–How far are we from daily practice? W Filipiak, B Bojko TrAC Trends in Analytical Chemistry 115, 203-213, 2019 | 74 | 2019 |
Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease A Pizzini, W Filipiak, J Wille, C Ager, H Wiesenhofer, R Kubinec, J Blaško, ... Journal of breath research 12 (3), 036002, 2018 | 72 | 2018 |
3-Heptanone as a potential new marker for valproic acid therapy S Erhart, A Amann, E Haberlandt, G Edlinger, A Schmid, W Filipiak, ... Journal of breath research 3 (1), 016004, 2009 | 71 | 2009 |
Optimization of sampling parameters for collection and preconcentration of alveolar air by needle traps W Filipiak, A Filipiak, C Ager, H Wiesenhofer, A Amann Journal of breath research 6 (2), 027107, 2012 | 60 | 2012 |